Mellissa Bryant

Senior Researcher


Mellissa has a clinical nursing background as a senior research coordinator in infectious diseases, clinical trial site management experience via industry and public health organisations positions.

Her various roles have permitted Mellissa to work with marginalised populations in accessing new health care treatments.


Australian Nurses and Midwives Federation


  • current – Senior Researcher Burnet Institute
  • current - Senior Clinical Trial Coordinator, Infectious Diseases Alfred Health (part time)
  • current- Affiliated Position with Monash University – Central Clinical School –Dept of Medicine
  • Site Manager Bristol Myers Squibb
  • Clinical Research Coordinator, Infectious Diseases, Monash Health
  • Nurse Bank Homeless People Program RDNS
  • Clinical Research Coordinator, Rheumatology Department Monash Health


  • Graduate Diploma in Community Health Nursing (Victoria University)
  • Registered Nurse

Projects (3)

Current (3)

  • EC Australia: Eliminate Hepatitis C Australia Partnership

  • EC Partnership: Eliminate Hepatitis C Partnership

  • The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19

Publications (3)

2022 (1)

  • Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial.
    McMahon JH, Lau JSY, Coldham A, Roney J, Hagenauer M, Price S, Bryant M, Garlick J, Paterson A, Lee SJ, O'Bryan J, Hearps A, Tachedjian G, Pinskier H, Phillips C, Garrow S, Pinskier N, Melvin R, Blakeway L, Wisniewski JA, Byers S, Badoordeen GZ, Pereira S, Pragastis K, Trubiano JA, Chua KYL, Kainer M, Molton JS, Gardiner BJ, Pierce AB, Cheng A, Rogers BA, Peleg AY
    EClinicalMedicine. 2022 Dec; 54:101703

2021 (2)